| Adapalene loaded solid lipid nanoparticles gel: an effective approach for acne treatment AK Jain, A Jain, NK Garg, A Agarwal, A Jain, SA Jain, RK Tyagi, RK Jain, ... Colloids and Surfaces B: Biointerfaces 121, 222-229, 2014 | 182 | 2014 |
| Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin A Jain, P Kesharwani, NK Garg, A Jain, SA Jain, AK Jain, P Nirbhavane, ... Colloids and Surfaces B: Biointerfaces 134, 47-58, 2015 | 153 | 2015 |
| Surface engineered polymeric nanocarriers mediate the delivery of transferrin-methotrexate conjugates for an improved understanding of brain cancer. SV Jain A, Jain A, Garg NK, Tyagi RK, Singh B, Katare OP, Webster TJ Acta Biomaterialia 24, 140-151, 2015 | 148 | 2015 |
| Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder (s) NK Garg, G Sharma, B Singh, P Nirbhavane, RK Tyagi, R Shukla, ... International Journal of pharmaceutics 517 (1-2), 413-431, 2017 | 126 | 2017 |
| Rifampicin loaded chitosan nanoparticle dry powder presents an improved therapeutic approach for alveolar tuberculosis T Rawal, R Parmar, RK Tyagi, S Butani Colloids and Surfaces B: Biointerfaces 154, 321-330, 2017 | 125 | 2017 |
| Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-κB and FOXO1 NK Garg, RK Tyagi, B Singh, G Sharma, P Nirbhavane, V Kushwah, ... International journal of pharmaceutics 499 (1-2), 301-320, 2016 | 101 | 2016 |
| Fucose decorated solid-lipid nanocarriers mediate efficient delivery of methotrexate in breast cancer therapeutics KOP Garg NK, Singh B, Jain A, Nirbhavane P, Sharma R, Tyagi RK, Kushwah V ... Colloids Surf B Biointerfaces 146, 114-126, 2016 | 96 | 2016 |
| Site specific/targeted delivery of gemcitabine through anisamide anchored chitosan/poly ethylene glycol nanoparticles: an improved understanding of lung cancer therapeutic … NK Garg, P Dwivedi, C Campbell, RK Tyagi European journal of pharmaceutical sciences 47 (5), 1006-1014, 2012 | 85 | 2012 |
| Further improvements of the P. falciparum humanized mouse model L Arnold, RK Tyagi, P Meija, C Swetman, J Gleeson, JL Pérignon, ... PloS one 6 (3), e18045, 2011 | 83 | 2011 |
| Functionalized lipid–polymer hybrid nanoparticles mediated codelivery of methotrexate and aceclofenac: a synergistic effect in breast cancer with improved pharmacokinetics … NK Garg, RK Tyagi, G Sharma, A Jain, B Singh, S Jain, OP Katare Molecular pharmaceutics 14 (6), 1883-1897, 2017 | 82 | 2017 |
| Effective transdermal delivery of methotrexate through nanostructured lipid carriers in an experimentally induced arthritis model NK Garg, B Singh, RK Tyagi, G Sharma, OP Katare Colloids and surfaces B: biointerfaces 147, 17-24, 2016 | 82 | 2016 |
| A synergistic approach of adapalene-loaded nanostructured lipid carriers, and vitamin C co-administration for treating acne A Jain, NK Garg, A Jain, P Kesharwani, AK Jain, P Nirbhavane, RK Tyagi Drug Development and Industrial Pharmacy 42 (6), 897-905, 2016 | 82 | 2016 |
| Mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymers N K Garg, S Mangal, H Khambete, P K Sharma, R K Tyagi Recent Patents on Drug Delivery & Formulation 4 (2), 114-128, 2010 | 77 | 2010 |
| Elastic liposome-mediated transdermal immunization enhanced the immunogenicity of P. falciparum surface antigen, MSP-119 RK Tyagi, NK Garg, R Jadon, T Sahu, OP Katare, SK Dalai, A Awasthi, ... Vaccine 33 (36), 4630-4638, 2015 | 60 | 2015 |
| Development and characterization of single step self-assembled lipid polymer hybrid nanoparticles for effective delivery of methotrexate NK Garg, B Singh, G Sharma, V Kushwah, RK Tyagi, S Jain, OP Katare RSC advances 5 (77), 62989-62999, 2015 | 51 | 2015 |
| RNA pulsed dendritic cells: an approach for cancer immunotherapy NK Garg, P Dwivedi, P Prabha, RK Tyagi Vaccine 31 (8), 1141-1156, 2013 | 43 | 2013 |
| Nanostructured lipid carrier–mediated transdermal delivery of aceclofenac hydrogel present an effective therapeutic approach for inflammatory diseases NK Garg, N Tandel, SK Bhadada, RK Tyagi Frontiers in Pharmacology 12, 713616, 2021 | 41 | 2021 |
| Role of Novel Drug Delivery Vehicles in Nanobiomedicine RK Tyagi, N Garg, R Shukla, PS Bisen BoD–Books on Demand, 2020 | 41 | 2020 |
| Lipid–polymer hybrid nanocarrier-mediated cancer therapeutics: current status and future directions NK Garg, N Tandel, RS Jadon, RK Tyagi, OP Katare Drug discovery today 23 (9), 1610-1621, 2018 | 40 | 2018 |
| Vaccination Strategies against Malaria: novel carrier (s) more than a tour de force RK Tyagi, NK Garg, T Sahu Journal of controlled release 162 (1), 242-254, 2012 | 39 | 2012 |
